STOCK TITAN

Viracta Therapeutics Inc (VIRX) Net Income by Year

VIRX

Viracta Therapeutics Inc reported a net loss of $51.1M in fiscal year 2023. This represents a decrease of 3.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters Viracta Therapeutics Inc has filed alongside them.

FY2023 annual
Net Income -$51.1M
YoY -3.8%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2024, ended Sep 30, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VIRX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-KFY0910-K
Net Income-$51.1M-3.8%-$49.2M+57.1%-$114.8M-503.5%-$19.0M-40.3%-$13.6M+49.1%-$26.6M+24.9%-$35.5M+6.7%-$38.0M-3.7%-$36.7M+14.7%-$43.0M-24.3%-$34.6M+21.3%-$44.0M-118.2%-$20.1M+18.1%-$24.6M+38.9%-$40.2M

VIRX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-QQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-K
Net Income-$10.6M+16.2%-$9.8M+21.3%-$9.1M+25.1%N/A-$12.6M+29.0%-$12.5M-18.0%-$12.2M-15.8%N/A-$17.7M-19.0%-$10.6M-15.4%-$10.5M+86.7%N/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Viracta Therapeutics Inc financials

Frequently Asked Questions

What was Viracta Therapeutics Inc's net income in fiscal year 2023?

Viracta Therapeutics Inc reported a net loss of $51.1M in fiscal year 2023.

How fast is Viracta Therapeutics Inc's net income growing?

Viracta Therapeutics Inc (VIRX) net income fell by 3.8% year over year, from -$49.2M to -$51.1M in fiscal year 2023.

How has Viracta Therapeutics Inc's net income changed over the years?

Across the 15 fiscal years this page covers, Viracta Therapeutics Inc (VIRX) net income went from -$40.2M in fiscal year 2009 to -$51.1M in fiscal year 2023.

Viracta Therapeutics Inc (VIRX) reported -$10.6M in net income in Q3 2024. This represents an increase of 16.2% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Viracta Therapeutics Inc (VIRX) reported on that line in every period on record.